Skeletal Dysplasia Account Manager - Oklahoma City/Tulsa

Role: Skeletal Dysplasia Account Manager responsible for launching Infigratinib for achondroplasia, focusing on community engagement and sales growth in the Southwest region. Responsibilities: develop and execute territory business plans, build relationships with healthcare providers across multidisciplinary care teams, demonstrate deep expertise in achondroplasia and skeletal dysplasia, and collaborate with internal teams to maximize impact and compliance. Requirements: 8–10 years in pharma/biotech, 4+ years in rare or genetic diseases, BS/BA (MBA preferred), proven success in product launch, strong communication, and account management skills. High-Value: rare pediatric genetic condition, Achondroplasia, biologic therapy, launch phase, extensive provider and multidisciplinary stakeholder engagement, extensive travel. WorkSetup: hybrid with extensive travel within multiple territories.